The geko™ device, manufactured by Sky Medical Technology Ltd and distributed in Canada by Trudell Healthcare Solutions Inc., is a muscle pump activator that significantly improves blood flow by stimulating the body’s ‘muscle pumps.’
DOORwaY-90 Study for SIR-Spheres® Therapy as 1st-line Treatment for Hepatocellular Carcinoma Enrolls First Patient
The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres. It is being led by co-principal investigators Cheenu Kappadath, PhD and Dr. Armeen Mahvash.
In a published study, a team from Lawson Health Research Institute (LHSC), in Ontario Canada, has found that a simple medical device can reduce swelling after kidney transplantation.
Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence
The TITAN 1 Feasibility Study is a prospective, multicenter, feasibility study to characterize the procedure for the implantable TNM device in subjects with bladder incontinence.
MicroTransponder Reports: Positive Stroke Rehabilitation Clinical Trial Results for the Vivistim® Paired VNS™ System Published in The Lancet
The Lancet reports that patients receiving Vivistim® Paired VNS™ System therapy showed 2-3 times the improvement in upper extremity motor impairment and function compared to controls that received intense rehabilitation alone.
The LAVA Study, which stands for Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S.
Cala Health Reports: New Data Demonstrate How Cala Trio™ Enables a More Frequent Assessment of Hand Tremor Compared with In-Person Assessments in Patients with Essential Tremor and Supports Feasibility of Telemedicine Approaches for Essential Tremor Management
Data presented in two abstracts at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting.
The initial results of the first 160 treated women in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE) show the broad applicability of Transcervical Fibroid Ablation performed by the Sonata System to a wide range of fibroid types and sizes while maintaining an excellent safety profile.